|
HELD
|
Hellenic Dynamics PLC
|
GB
|
LSE
|
|
HEMO
|
Hemogenyx Pharmaceuticals Plc
|
UK
|
LSE
|
|
HGEN
|
Humanigen, Inc.
|
US
|
NASDAQ
|
|
HMTXF
|
Hemostemix Inc
|
US
|
OTC
|
|
HN3Q
|
Nova Mentis Life Science Corp
|
DE
|
F
|
|
HRBR
|
Harbor Biosciences Inc
|
US
|
OTC
|
|
HRTX
|
Heron Therapeutics, Inc.
|
US
|
NASDAQ
|
|
HSTC
|
Hst Global Inc
|
US
|
OTC
|
|
HUMAW
|
Humacyte Inc
|
US
|
US
|
|
HXBM
|
Helix Biomedix Inc
|
US
|
OTC
|
|
I1LM34
|
Illumina Inc.
|
BR
|
SA
|
|
I54
|
BIOCYTOGEN PHARMA. H YC1
|
DE
|
F
|
|
IBIO
|
iBio, Inc.
|
US
|
AMEX
|
|
IBO
|
Impact BioMedical, Inc.
|
US
|
US
|
|
IBRX
|
ImmunityBio, Inc.
|
US
|
NASDAQ
|
|
IBXNF
|
Ibex Techs Inc
|
US
|
OTC
|
|
ICCC
|
ImmuCell Corporation
|
US
|
NASDAQ
|
|
ICPT
|
Intercept Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ICUCW
|
LMF Acquisition Opportunities Inc
|
US
|
US
|
|
IDRA
|
Idera Pharmaceuticals, Inc.
|
US
|
NASDAQ
|